90 related articles for article (PubMed ID: 17957523)
1. Computed tomography features of recurrent ovarian carcinoma according to time to relapse.
Sahdev A; Hughes JH; Barwick T; Rockall AG; Gallagher CJ; Reznek RH
Acta Radiol; 2007 Nov; 48(9):1038-44. PubMed ID: 17957523
[TBL] [Abstract][Full Text] [Related]
2. Detection of recurrent ovarian cancer at MRI: comparison with integrated PET/CT.
Kim CK; Park BK; Choi JY; Kim BG; Han H
J Comput Assist Tomogr; 2007; 31(6):868-75. PubMed ID: 18043348
[TBL] [Abstract][Full Text] [Related]
3. Role of CT in the management of recurrent ovarian cancer.
Funt SA; Hricak H; Abu-Rustum N; Mazumdar M; Felderman H; Chi DS
AJR Am J Roentgenol; 2004 Feb; 182(2):393-8. PubMed ID: 14736669
[TBL] [Abstract][Full Text] [Related]
4. Combined PET/CT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodes.
Bristow RE; Giuntoli RL; Pannu HK; Schulick RD; Fishman EK; Wahl RL
Gynecol Oncol; 2005 Nov; 99(2):294-300. PubMed ID: 16051330
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma: a retrospective review.
Makhija S; Howden N; Edwards R; Kelley J; Townsend DW; Meltzer CC
Gynecol Oncol; 2002 Apr; 85(1):53-8. PubMed ID: 11925120
[TBL] [Abstract][Full Text] [Related]
6. Recurrent endometrial cancer: patterns of recurrent disease and assessment of prognosis.
Sohaib SA; Houghton SL; Meroni R; Rockall AG; Blake P; Reznek RH
Clin Radiol; 2007 Jan; 62(1):28-34; discussion 35-6. PubMed ID: 17145260
[TBL] [Abstract][Full Text] [Related]
7. Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer.
Thrall MM; DeLoia JA; Gallion H; Avril N
Gynecol Oncol; 2007 Apr; 105(1):17-22. PubMed ID: 17208284
[TBL] [Abstract][Full Text] [Related]
8. Solitary recurrent metastasis of epithelial ovarian cancer in the spleen.
Farias-Eisner R; Braly P; Berek JS
Gynecol Oncol; 1993 Mar; 48(3):338-41. PubMed ID: 8462900
[TBL] [Abstract][Full Text] [Related]
9. The role of CT in the evaluation of ovarian malignancy.
Amendola MA
Crit Rev Diagn Imaging; 1985; 24(4):329-68. PubMed ID: 3896652
[TBL] [Abstract][Full Text] [Related]
10. Relapse and survival in early-stage ovarian cancer.
Lenhard SM; Bufe A; Kümper C; Stieber P; Mayr D; Hertlein L; Kirschenhofer A; Friese K; Burges A
Arch Gynecol Obstet; 2009 Jul; 280(1):71-7. PubMed ID: 19093129
[TBL] [Abstract][Full Text] [Related]
11. [Role of positron emission tomography in diagnosis of recurrent ovarian cancer].
Ding XL; Shen K; Lang JH; Wu M; Huang HF; Pan LY; Yang JX
Zhonghua Fu Chan Ke Za Zhi; 2003 Nov; 38(11):667-9. PubMed ID: 14728852
[TBL] [Abstract][Full Text] [Related]
12. Ovarian serous tumors of low malignant potential with nodal low-grade serous carcinoma.
Djordjevic B; Malpica A
Am J Surg Pathol; 2012 Jul; 36(7):955-63. PubMed ID: 22613998
[TBL] [Abstract][Full Text] [Related]
13. Transitional cell carcinoma of the bladder: patterns of recurrence after cystectomy as determined by CT.
Ellis JH; McCullough NB; Francis IR; Grossman HB; Platt JF
AJR Am J Roentgenol; 1991 Nov; 157(5):999-1002. PubMed ID: 1927826
[TBL] [Abstract][Full Text] [Related]
14. (18)F-FDG PET/CT in the evaluation of recurrent ovarian cancer: a prospective study on forty-one patients.
Nanni C; Rubello D; Farsad M; De Iaco P; Sansovini M; Erba P; Rampin L; Mariani G; Fanti S
Eur J Surg Oncol; 2005 Sep; 31(7):792-7. PubMed ID: 15893908
[TBL] [Abstract][Full Text] [Related]
15. Positive emission tomography for evaluating a complete clinical response in patients with ovarian or peritoneal carcinoma: correlation with second-look laparotomy.
Rose PG; Faulhaber P; Miraldi F; Abdul-Karim FW
Gynecol Oncol; 2001 Jul; 82(1):17-21. PubMed ID: 11426956
[TBL] [Abstract][Full Text] [Related]
16. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
17. Combined FDG-positron emission tomography and computed tomography for the detection of ovarian cancer recurrence in an inguinal hernia sac.
Díaz-Montes TP; Jacene HA; Wahl RL; Bristow RE
Gynecol Oncol; 2005 Sep; 98(3):510-2. PubMed ID: 15992914
[TBL] [Abstract][Full Text] [Related]
18. Impact of FDG PET-CT imaging on the decision making in the biologic suspicion of ovarian carcinoma recurrence.
Soussan M; Wartski M; Cherel P; Fourme E; Goupil A; Le Stanc E; Callet N; Alexandre J; Pecking AP; Alberini JL
Gynecol Oncol; 2008 Jan; 108(1):160-5. PubMed ID: 17961640
[TBL] [Abstract][Full Text] [Related]
19. Recurrent ovarian malignancy: patterns and spectrum of imaging findings.
Park CM; Kim SH; Kim SH; Moon MH; Kim KW; Choi HJ
Abdom Imaging; 2003; 28(3):404-15. PubMed ID: 12719914
[TBL] [Abstract][Full Text] [Related]
20. Recurrent ovarian granulosa cell tumors: clinical and imaging features.
Rha SE; Oh SN; Jung SE; Lee YJ; Lee AW; Byun JY
Abdom Imaging; 2008; 33(1):119-25. PubMed ID: 17624570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
